Fulltext

Dexmedetomidine for analgesia and sedation for procedural pain or discomfort in newborn infants

Lai NM 1 , Fiander M 2 , Cracknell J 3 , Tan K 4 , Romantsik O 5

Affiliations 

  • 1 School of Medicine, Taylor's University, Subang Jaya, Malaysia
  • 2 Cochrane Neonatal, Vermont Oxford Network, Burlington, Vermont, USA
  • 3 Cochrane Neonatal, Vermont Oxford Network, Oxford, UK
  • 4 Department of Paediatrics, Monash University, Melbourne, Australia
  • 5 Department of Clinical Sciences Lund, Paediatrics, Lund University, Skåne University Hospital, Lund, Sweden
Cochrane Database Syst Rev, 2025 Jan 28;1(1):CD014212.
PMID: 39873291 DOI: 10.1002/14651858.CD014212

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of dexmedetomidine compared with opioids, non-opioids and placebo in providing sedation and analgesia for procedural pain in newborn infants.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications